EUVIMEDEUVIMED entdecken
Crossref

Indications for sentinel lymph node biopsy in node‐negative oral cancers

Taijiro Ozawa, Isao Oze, Takashi Matsuzuka, Eiichi Sasaki, Junkichi Yokoyama, Yoshie Sano, Masayuki Tomifuji iD, Koji Araki iD, Yasunao Kogashiwa, Ichiro Tateya, Shinya Agena, Tomohiro Sakashita und 9 weitere

Head & Neck · 2023

DOI: 10.1002/hed.27477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Taijiro Ozawa und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Toyohashi Municipal Hospital, Toyohashi, Japan. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Mouth Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to define the indications for sentinel lymph node biopsy (SLNB), the third option for cervical treatment in oral cancer with negative cervical lymph nodes.

Methods

The greatest depth of invasion (DOI) and long diameter (LD) of the primary site were used as exposures. SLN metastasis was considered the outcome.

Results

In three trials conducted between 2009 and 2016, 158 patients were eligible and reassigned to this study group. The scatterplot based on the respective values of DOI and LD would eventually be divided into three sections. In cases of sections T1, T2, and T3, the proportions of SLN metastasis positivity were 21.3%, 35.3%, and 51.2%, respectively. In certain cases of T1 with 2 mm < DOI ≤ 5 mm and 8 mm < LD ≤ 20 mm, the proportion of SLN metastasis positivity was 40.9%.

Conclusions

SLNB‐navigated or assisted neck dissection can be added as an effective procedure for N0 neck control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sentinel Lymph Node BiopsyMouth NeoplasmsHumansLymphatic MetastasisLymph NodesNeck Dissection

Stichwörter der Autor:innen

indicationneck dissectionnode-negativeoral cavity cancersentinel lymph node biopsy

Autor:innen und Institutionen

  • Department of Otolaryngology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Department of Head and Neck Surgery - Otolaryngology, Asahi University Hospital, Gifu, Japan.
  • Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Department of Otolaryngology - Head and Neck Surgery, Nadogaya Hospital, Kashiwa, Japan.
  • Department of Oral and Maxillofacial Surgery, Saitama Medical University, Saitama, Japan.

ORCID-Profile: Masayuki Tomifuji, Koji Araki, Hidenori Suzuki, Yasuhisa Hasegawa

Zitieren

APA

Ozawa, T., Oze, I., Matsuzuka, T., Sasaki, E., Yokoyama, J., Sano, Y., Tomifuji, M., Araki, K., Kogashiwa, Y., Tateya, I., Agena, S., Sakashita, T., Tsuzuki, H., Terada, H., Suzuki, H., Nishikawa, D., Beppu, S., Matoba, T., Mukoyama, N., …, & Hasegawa, Y. (2023). Indications for sentinel lymph node biopsy in node‐negative oral cancers. Head & Neck. https://doi.org/10.1002/hed.27477

Vancouver

Ozawa T, Oze I, Matsuzuka T, Sasaki E, Yokoyama J, Sano Y, et al. Indications for sentinel lymph node biopsy in node‐negative oral cancers. Head & Neck. 2023. doi:10.1002/hed.27477

BibTeX
@article{Ozawa2023,
  author = {Ozawa, Taijiro and Oze, Isao and Matsuzuka, Takashi and Sasaki, Eiichi and Yokoyama, Junkichi and Sano, Yoshie and Tomifuji, Masayuki and Araki, Koji and Kogashiwa, Yasunao and Tateya, Ichiro and Agena, Shinya and Sakashita, Tomohiro and Tsuzuki, Hidenori and Terada, Hoshino and Suzuki, Hidenori and Nishikawa, Daisuke and Beppu, Shintarou and Matoba, Takuma and Mukoyama, Nobuaki and Oguri, Keisuke and Hasegawa, Yasuhisa},
  title = {Indications for sentinel lymph node biopsy in node‐negative oral cancers},
  journal = {Head & Neck},
  year = {2023},
  doi = {10.1002/hed.27477}
}
Kostenlos starten →